Highlights INVO Fertility, Inc.

Equities

IVF

US44984F6097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 07/07/2025 BST			5-day change	1st Jan Change
0.8099 ^USD	-6.26%		-7.96%	-91.67%

06-30	Invo Fertility, Inc. Adds Platelet-Rich Plasma Therapy Capabilities At Wisconsin Fertility Institute	CI
06-25	INVO Fertility, Inc. Receives Notice of Allowance for Modified INVOcell Device Patent	CI

Highlights

Invo Fertility, Inc. Adds Platelet-Rich Plasma Therapy Capabilities At Wisconsin Fertility Institute	06-30	CI
INVO Fertility, Inc. Receives Notice of Allowance for Modified INVOcell Device Patent	06-25	CI
INVO Fertility Secures US Patent Allowance for INVOcell's New Version	06-25	MT
Invo Fertility, Inc. Expands Telehealth Capabilities At Its Wisconsin Fertility Institute	06-18	CI
INVO Fertility Seeks Acquisitions	05-25	CI
INVO Fertility, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	05-20	CI
Top Premarket Gainers	05-05	MT
Invo Fertility Announces 2024 Financial Results	04-30	RE
INVO Fertility, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	04-30	CI
INVO Fertility, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	04-30	CI
NAYA Biosciences Renames Itself INVO Fertility; Separates Oncology, Fertility Businesses	04-15	MT
Naya Biosciences Announces Development of Ny-500, A Novel Ai-Optimized Pd-1 X Vegf Bifunctional Antibody	01-06	CI
NAYA Biosciences, Inc. Announces Executive and Board Appointments	12-12	CI
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	24/10/24	CI
INVO Bioscience Completes Merger With NAYA Biosciences Acquisition	14/10/24	MT
NAYA Biosciences completed the acquisition of INVO Bioscience, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	13/10/24	CI
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Loss $-0.62 Per Share	14/08/24	MT
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Revenue $1.8M	14/08/24	MT
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	14/08/24	CI
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05/24	CI
Top Premarket Decliners	18/04/24	MT
Sector Update: Health Care Stocks Retreating Late Afternoon	17/04/24	MT
Top Midday Gainers	17/04/24	MT
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly	17/04/24	MT
Top Premarket Gainers	17/04/24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights INVO Fertility, Inc.

Equities

IVF

US44984F6097

Medical Equipment, Supplies & Distribution

Highlights

Filters